Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results